Treatment of bacterial meningitis.

Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev (2000) 3.69

Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model. Antimicrob Agents Chemother (2004) 2.76

Management of infections due to antibiotic-resistant Streptococcus pneumoniae. Clin Microbiol Rev (1998) 2.13

Steroids in bacterial meningitis: yes. J Neural Transm (Vienna) (2012) 1.48

Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis. Antimicrob Agents Chemother (2007) 1.40

Diagnosis and treatment of bacterial meningitis. Arch Dis Child (2003) 1.39

Ciprofloxacin-resistant Neisseria meningitidis, Delhi, India. Emerg Infect Dis (2007) 1.28

Difficult and recurrent meningitis. J Neurol Neurosurg Psychiatry (2004) 1.22

Nosocomial outbreak of neonatal Salmonella enterica serotype Enteritidis meningitis in a rural hospital in northern Tanzania. BMC Infect Dis (2004) 1.16

Prevalence of antimicrobial drug-resistant Streptococcus pneumoniae in Washington State. West J Med (1998) 1.12

Neisseria meningitidis induces brain microvascular endothelial cell detachment from the matrix and cleavage of occludin: a role for MMP-8. PLoS Pathog (2010) 1.11

Clinical features, acute complications, and outcome of Salmonella meningitis in children under one year of age in Taiwan. BMC Infect Dis (2011) 1.09

Laboratory-based surveillance of patients with bacterial meningitis in Egypt (1998-2004). Eur J Clin Microbiol Infect Dis (2007) 1.07

Clonal groups of penicillin-nonsusceptible Streptococcus pneumoniae in Baltimore, Maryland: a population-based, molecular epidemiologic study. J Clin Microbiol (2000) 1.04

Decrease in serum procalcitonin levels over time during treatment of acute bacterial meningitis. Crit Care (2005) 1.03

Total variation in the penA gene of Neisseria meningitidis: correlation between susceptibility to beta-lactam antibiotics and penA gene heterogeneity. Antimicrob Agents Chemother (2006) 0.98

Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus. Thorax (2003) 0.97

Gentamicin increases the efficacy of vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model. Antimicrob Agents Chemother (2002) 0.97

Nonculture prediction of Neisseria meningitidis susceptibility to penicillin. Antimicrob Agents Chemother (2001) 0.96

Reprogramming the host response in bacterial meningitis: how best to improve outcome? Clin Microbiol Rev (2003) 0.95

Penetration of rufloxacin into the cerebrospinal fluid in patients with inflamed and uninflamed meninges. Antimicrob Agents Chemother (2000) 0.93

Streptococcus pneumoniae damages the ciliated ependyma of the brain during meningitis. Infect Immun (2003) 0.90

Infectious disease: do steroids benefit patients with bacterial meningitis? Nat Rev Neurol (2010) 0.90

Use of an oxacillin disk screening test for detection of penicillin- and ceftriaxone-resistant pneumococci. J Clin Microbiol (1999) 0.89

Inhibition of Escherichia coli-induced meningitis by carboxyfullerence. Antimicrob Agents Chemother (1999) 0.86

Fluid management of bacterial meningitis in developing countries. Arch Dis Child (1998) 0.83

Combination of daptomycin plus ceftriaxone is more active than vancomycin plus ceftriaxone in experimental meningitis after addition of dexamethasone. Antimicrob Agents Chemother (2009) 0.82

Enhancement of antimicrobial effects by glucocorticoids. Med Microbiol Immunol (2003) 0.82

Bacterial Meningitis: Principles and Practical Aspects of Therapy. Curr Infect Dis Rep (2000) 0.82

Acute Meningitis. Curr Infect Dis Rep (1999) 0.81

Chemotactic factors in cerebrospinal fluid during bacterial meningitis. Infect Immun (2006) 0.81

Meropenem therapy failure in Listeria monocytogenes infection. Eur J Clin Microbiol Infect Dis (2004) 0.80

Pre-ischemic Treatment with Ampicillin Reduces Neuronal Damage in the Mouse Hippocampus and Neostriatum after Transient Forebrain Ischemia. Korean J Physiol Pharmacol (2008) 0.79

Dexamethasone and antibiotics for the empirical treatment of bacterial meningitis in Canadian children: A survey of paediatric infectious diseases specialists. Paediatr Child Health (2002) 0.79

Therapeutic efficacy of meropenem for treatment of experimental penicillin-resistant pneumococcal meningitis. J Korean Med Sci (2004) 0.78

Acute meningoencephalitis in hospitalised children in southern Bangladesh. Malays J Med Sci (2012) 0.78

Isolated septic arthritis: meningococcal infection. J R Soc Med (2003) 0.78

Central Nervous System Infections in the Immune-competent Adult. Curr Treat Options Neurol (2002) 0.77

Severe community-acquired meningitis. Crit Care (1999) 0.77

Evidence for intrathecal synthesis of alternative pathway complement activation proteins in experimental meningitis. Am J Pathol (1997) 0.77

Salmonella enterica Serotype Arizonae Meningitis in a Neonate. Case Rep Pediatr (2013) 0.77

A case of meningoencephalitis caused by Listeria monocytogenes in a healthy child. Korean J Pediatr (2010) 0.75

Acute obstructive hydrocephalus complicating bacterial meningitis. In meningitis, one antibiotic is better than than two. BMJ (1999) 0.75

Treatment of bacterial infections. N Engl J Med (1997) 0.75

First Report of a Case of Pneumococcal Meningitis Which Did Not Respond to the Ceftriaxone Therapy despite the Isolated Organism Being Sensitive to This Antibiotic In Vitro. Case Rep Pulmonol (2011) 0.75

The microbes strike back. CMAJ (1997) 0.75

Immunoinformatics Approach in Designing Epitope-based Vaccine Against Meningitis-inducing Bacteria (Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae Type b). Drug Target Insights (2016) 0.75

Neisseria meningitidis C:2b:P1.2,5 with decreased susceptibility to penicillin isolated from a patient with meningitis and purpura fulminans. Eur J Clin Microbiol Infect Dis (2005) 0.75

Early symptomatic and late seizures in Kosovar children with bacterial meningitis. Childs Nerv Syst (2011) 0.75

Early neurologic complications and long-term sequelae of childhood bacterial meningitis in a limited-resource country (Kosovo). Childs Nerv Syst (2012) 0.75

A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute. N Engl J Med (1994) 9.11

Acute bacterial meningitis. Lancet (1996) 6.47

Bacterial adherence in the pathogenesis of endocarditis. Interaction of bacterial dextran, platelets, and fibrin. J Clin Invest (1978) 4.38

Combination antibiotic therapy of bacterial endocarditis. Ann Intern Med (1980) 3.03

Infectious etiologies of rhabdomyolysis: three case reports and review. Clin Infect Dis (1996) 2.80

Bacterial meningitis: pathogenesis, pathophysiology, and progress. N Engl J Med (1992) 2.40

Bacterial meningitis: recent advances in pathophysiology and treatment. Ann Intern Med (1990) 2.11

Recent development of rigors during infusion of urokinase: is it related to an endotoxin? J Vasc Interv Radiol (1994) 2.01

In vitro binding of Candida albicans yeast cells to human fibronectin. Can J Microbiol (1984) 1.98

Bactericidal versus bacteriostatic antibiotic therapy of experimental pneumococcal meningitis in rabbits. J Clin Invest (1983) 1.93

Comparative pharmacology of cefaclor and cephalexin. Antimicrob Agents Chemother (1977) 1.86

Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor. J Clin Invest (1991) 1.77

The postantibiotic effect in the treatment of experimental meningitis caused by Streptococcus pneumoniae in rabbits. J Infect Dis (1984) 1.67

Pharmacokinetics of cefoperazone in normal volunteers and subjects with renal insufficiency. Antimicrob Agents Chemother (1981) 1.66

Cerebrospinal fluid outflow resistance in rabbits with experimental meningitis. Alterations with penicillin and methylprednisolone. J Clin Invest (1980) 1.64

Morphologic alterations of the blood-brain barrier with experimental meningitis in the rat. Temporal sequence and role of encapsulation. J Clin Invest (1986) 1.63

Response to therapy in an experimental rabbit model of meningitis due to Listeria monocytogenes. J Infect Dis (1979) 1.57

Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A(2A) receptor agonists. Br J Pharmacol (2001) 1.53

Moxalactam and cefazolin: comparative pharmacokinetics in normal subjects. Antimicrob Agents Chemother (1981) 1.51

In vitro susceptibility studies with cefaclor and cephalexin. Antimicrob Agents Chemother (1977) 1.51

Microbial adhesion to fibronectin in vitro correlates with production of endocarditis in rabbits. Proc Soc Exp Biol Med (1985) 1.50

Intermittent or continuous therapy of experimental meningitis due to Streptococcus pneumoniae in rabbits: preliminary observations on the postantibiotic effect in vivo. Rev Infect Dis (1981) 1.49

Yeast adhesion in the pathogenesis of endocarditis due to Candida albicans: studies with adherence-negative mutants. J Infect Dis (1985) 1.48

Predicting pass rates on the American Board of Internal Medicine certifying examination. J Gen Intern Med (1998) 1.47

Haemophilus influenzae lipopolysaccharide-induced blood brain barrier permeability during experimental meningitis in the rat. J Clin Invest (1988) 1.47

Primary prevention of cryptococcal meningitis by fluconazole in HIV-infected patients. Lancet (1995) 1.46

Pathogenesis and pathophysiology of bacterial meningitis. Clin Microbiol Rev (1993) 1.45

The use of corticosteroids in the management of bacterial meningitis in adults. J Antimicrob Chemother (1996) 1.43

Issues in the management of bacterial meningitis. Am Fam Physician (1997) 1.40

Influence of preformed antibody on experimental Streptococcus sanguis endocarditis. Infect Immun (1979) 1.36

Postsplenectomy sepsis with DF-2: report of a case with isolation of the organism from the patient's dog. Ann Intern Med (1980) 1.34

Pharmacokinetics of moxalactam in subjects with various degrees of renal dysfunction. Antimicrob Agents Chemother (1980) 1.34

Infections of the central nervous system. Adv Intern Med (1998) 1.33

The challenge of penicillin-resistant Streptococcus pneumoniae meningitis: current antibiotic therapy in the 1990s. Clin Infect Dis (1997) 1.33

Bacterial adhesion in the pathogenesis of infective endocarditis. Effect of subinhibitory antibiotic concentrations on streptococcal adhesion in vitro and the development of endocarditis in rabbits. J Clin Invest (1981) 1.31

Evaluation of aztreonam in experimental bacterial meningitis and cerebritis. Antimicrob Agents Chemother (1983) 1.26

Pharmacokinetics of aztreonam in patients with various degrees of renal dysfunction. Antimicrob Agents Chemother (1983) 1.23

Haemophilus influenzae outer membrane vesicle-induced blood-brain barrier permeability during experimental meningitis. Infect Immun (1989) 1.22

Imipenem therapy of experimental Staphylococcus aureus and Streptococcus faecalis endocarditis. J Antimicrob Chemother (1983) 1.20

Comparison of netilmicin with gentamicin in the therapy of experimental Escherichia coli meningitis. Antimicrob Agents Chemother (1978) 1.18

Pneumonia treated with imipenem/cilastatin. Am J Med (1985) 1.18

Comparison of cefoperazone with penicillin, ampicillin, gentamicin, and chloramphenicol in the therapy of experimental meningitis. Antimicrob Agents Chemother (1982) 1.18

Neutrophil A2A adenosine receptor inhibits inflammation in a rat model of meningitis: synergy with the type IV phosphodiesterase inhibitor, rolipram. J Infect Dis (1999) 1.18

Strategies for stemming the tide of antimicrobial resistance. JAMA (1998) 1.15

Problems in salmonellosis: rationale for clinical trials with newer beta-lactam agents and quinolones. Rev Infect Dis (1986) 1.14

Etiology and mortality of bacterial meningitis in northeastern Brazil. Rev Infect Dis (1990) 1.13

The microbial etiology and antimicrobial therapy of adults with acute community-acquired sinusitis: a fifteen-year experience at the University of Virginia and review of other selected studies. J Allergy Clin Immunol (1992) 1.12

Diagnostic value of echocardiography in suspected endocarditis. An evaluation based on the pretest probability of disease. Circulation (1996) 1.11

Clearance of bacteria from cerebrospinal fluid to blood in experimental meningitis. Infect Immun (1979) 1.10

Effect of methylprednisolone on entry of ampicillin and gentamicin into cerebrospinal fluid in experimental pneumococcal and Escherichia coli meningitis. Antimicrob Agents Chemother (1983) 1.07

Mechanisms of brain injury in bacterial meningitis: workshop summary. Clin Infect Dis (1994) 1.04

Rifampin in experimental endocarditis due to Staphylococcus aureus in rabbits. Rev Infect Dis (1983) 1.03

Enzyme-linked immunosorbent assay for detection of Streptococcus pneumoniae antigen. J Clin Microbiol (1979) 1.01

Role of fibronectin in the pathogenesis of candidal infections. Rev Infect Dis (1988) 1.01

Enigmatic enterococcal endocarditis. Ann Intern Med (1984) 1.01

Effect of a vancomycin restriction policy on ordering practices during an outbreak of vancomycin-resistant Enterococcus faecium. Arch Intern Med (1997) 1.00

Comparison of ciprofloxacin with azlocillin plus tobramycin in the therapy of experimental Pseudomonas aeruginosa endocarditis. Antimicrob Agents Chemother (1985) 0.99

Oral ciprofloxacin therapy for gram-negative bacillary osteomyelitis. Am J Med (1987) 0.98

Co-trimoxazole versus nafcillin in the therapy of experimental meningitis due to Staphylococcus aureus. J Antimicrob Chemother (1987) 0.94

Rigid nasal endoscopy versus sinus puncture and aspiration for microbiologic documentation of acute bacterial maxillary sinusitis. Clin Infect Dis (2001) 0.94

Role of cerebrospinal fluid pleocytosis and Haemophilus influenzae type b capsule on blood brain barrier permeability during experimental meningitis in the rat. J Clin Invest (1988) 0.94

Pathophysiological correlates in bacterial meningitis. J Infect (1981) 0.93

A pseudo-outbreak of nosocomial infections associated with the introduction of an antibiotic management programme. J Hosp Infect (2003) 0.93

Evaluation of mezlocillin in discriminative animal models of infection. J Antimicrob Chemother (1982) 0.92

Comparison of ceftriaxone and ampicillin plus chloramphenicol for the therapy of acute bacterial meningitis. Antimicrob Agents Chemother (1985) 0.92

Mecillinam-ampicillin synergism in experimental Enterobacteriaceae meningitis. Antimicrob Agents Chemother (1979) 0.91

Clindamycin therapy of experimental Staphylococcus aureus endocarditis. Antimicrob Agents Chemother (1982) 0.90

Influence of preformed antibody on the pathogenesis of experimental Candida albicans endocarditis. Infect Immun (1983) 0.89

Evaluation of azlocillin in vitro and in discriminative animal models of infection. J Antimicrob Chemother (1983) 0.89

Staphylococcus aureus ventriculitis treated with single-dose intraventricular vancomycin or daptomycin (LY146032): bacterial and antibiotic kinetics in hydrocephalic rabbits. Antimicrob Agents Chemother (1990) 0.89

Theoretical and practical considerations of antibiotic therapy for bacterial meningitis. Pediatr Infect Dis (1985) 0.88

Ciprofloxacin in the treatment of Staphylococcus aureus osteomyelitis. A review. Diagn Microbiol Infect Dis (1990) 0.88

New perspectives on bacterial meningitis. Clin Infect Dis (1993) 0.88

Potential role of nitric oxide in the pathophysiology of experimental bacterial meningitis in rats. Infect Immun (1995) 0.88

Therapy of experimental meningitis due to Salmonella enteritidis. Antimicrob Agents Chemother (1992) 0.87

Moxalactam for the treatment of bacterial meningitis in children. J Infect Dis (1983) 0.87

Comparison of once-daily cephalosporin regimens for community-acquired lower respiratory tract infections in patients with chronic lung disease. Clin Ther (1989) 0.87

Blood-brain barrier alterations in bacterial meningitis: development of an in vitro model and observations on the effects of lipopolysaccharide. In Vitro Cell Dev Biol (1991) 0.86

Societal costs versus savings from wild-card patent extension legislation to spur critically needed antibiotic development. Infection (2007) 0.86

Rationale for optimal dosing of beta-lactam antibiotics in therapy for bacterial meningitis. Eur J Clin Microbiol (1984) 0.86

Pharmacokinetics of multiple-dose cefoperazone in hemodialysis patients. Am J Nephrol (1985) 0.86

Brain injury in bacterial meningitis: therapeutic implications. Curr Opin Neurol (1997) 0.86

Detection of circulating antigen in experimental Candida albicans endocarditis by an enzyme-linked immunosorbent assay. J Clin Microbiol (1980) 0.85

Comparison of cyclacillin and amoxicillin for therapy for acute maxillary sinusitis. Antimicrob Agents Chemother (1986) 0.85

Recent advances in the pathogenesis and pathophysiology of bacterial meningitis. Am J Med Sci (1986) 0.84

Pulmonary infection with capsule-deficient cryptococcus neoformans. Virchows Arch A Pathol Anat Histol (1979) 0.84

Adjunctive therapy for bacterial meningitis: rationale for use, current status, and prospects for the future. Clin Infect Dis (1993) 0.84

Time course of hearing loss in an animal model of pneumococcal meningitis. Otolaryngol Head Neck Surg (1999) 0.84

Applications of therapy in animal models to bacterial infection in human disease. Infect Dis Clin North Am (1989) 0.83

Fever in neurologic diseases. Infect Dis Clin North Am (1996) 0.83

Brain abscess. Clin Neuropharmacol (1987) 0.83

Cross-linked bispecific monoclonal antibody heteropolymers facilitate the clearance of human IgM from the circulation of squirrel monkeys. Eur J Immunol (1994) 0.83

Intracranial blastomycoma. Medicine (Baltimore) (1987) 0.82

Bacterial meningitis in the patient at risk: intrinsic risk factors and host defense mechanisms. Am J Med (1984) 0.82

Effects of sub-bactericidal concentrations of antibiotics in experimental models of endocarditis. J Antimicrob Chemother (1985) 0.82

Pathogenesis and pathophysiology of meningitis. Infect Dis Clin North Am (1990) 0.82

Factors influencing the pathogenesis and prevention of infective endocarditis. Scand J Infect Dis Suppl (1982) 0.82

Experimental studies of biliary excretion of piperacillin. Ann Surg (1987) 0.82

Alterations of the blood-brain barrier in bacterial meningitis: in vivo and in vitro models. Pediatr Infect Dis J (1989) 0.82

Septic sacroiliitis due to Proteus mirabilis. South Med J (1990) 0.82